|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/454 | (2006.01) |
| A61K 31/69 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 38/55 | (2006.01) |
| (11) | Number of the document | 2068874 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07840746.7 |
| Date of filing the European patent application | 2007-08-07 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-28 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/US2007/075403 |
| Date | 2007-08-07 |
| (87) | Number | WO 2008/019378 |
| Date | 2008-02-14 |
| (30) | Number | Date | Country code |
| 836185 P | 2006-08-07 | US | |
| 944262 P | 2007-06-15 | US |
| (72) |
AFAR, Daniel, US
ANDERSON, Kenneth, C., US
TAI, Yu-Tzu, US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215-5450, US |
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Dauginės mielomos, naudojant kombinuotas terapijas, pagrįstas anti-CS1 antikūnais, gydymo būdai |
| METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-07-10 | 19 | 347.00 EUR |
| 2026-08-07 |